peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment Skip to main contentSkip to navigationSkip to search
HNSA   ( ,  %) SEK
Quotes are delayed 15 minutes

Annual Report 2007 (In Swedish)

23 Apr 2008, 08:00
Regulatory information

The annual report for Hansa Medical 2007 (In Swedish) is available as PDF April 23, 2008 through A print version of the annual report can be ordered through info@hansamedical.comLund April 23, 2008Hansa Medical AB (publ)For more information, please contact:Emanuel Björne, CEOMobile: +46 (0)70 717 54 77E-mail: emanuel.bjorne@hansamedical.comHansa Medical refines biomedical discoveries into candidate drugs and diagnostic analytical methods. The company’s long-term goal is to bring new products to market through collaboration agreements with pharmaceutical and diagnostics companies. Hansa Medical’s lead project, IdeS, is an innovative drug for treatment in conjunction with organ transplantation and autoimmune disease. The company also pursues other development projects, including diagnostics and drugs for sepsis and drugs for rheumatoid arthritis.